Published ahead of print on December 4, 2002, doi:10.1164/rccm.200207-710OC
Am. J. Respir. Crit. Care Med., Volume 167, Number 5, March 2003, 751-757
A more recent version of this article appeared on March 1, 2003
Submitted on July 17, 2002
Accepted on November 18, 2002
VASCULAR COMPONENT OF AIRWAY REMODELING IN ASTHMA IS REDUCED BY HIGH DOSE OF FLUTICASONE
Alfredo Chetta1*, Andrea Zanini2, Antonio Foresi3, Mario Del Donno1, Antonio Castagnaro1, Raffaele D'Ippolito1, Simonetta Baraldo4, Renato Testi5, Marina Saetta4, and Dario Olivieri1
1 Department of Clinical Sciences, Section of Respiratory Diseases, University of Parma, Parma, Italy,
2 IRCCS Rehabilitation Institute of Tradate, Division of Pneumology, Salvatore Maugeri Foundation, Tradate, Italy,
3 Respiratory Pathophysiology Laboratory, Sesto San Giovanni Hospital, Sesto San Giovanni, Italy,
4 Department of Clinical and Experimental Medicine, Section of Respiratory Diseases, University of Padua, Padua, Italy,
5 Research and Development Unit, GSK, Verona, Italy
* To whom correspondence should be addressed. E-mail: chetta{at}unipr.it.
We conducted a randomized double-blind, parallel-group study to assess the effect of six weeks treatment with low dose (100 µg, bid) or high dose (500 µg, bid) inhaled fluticasone propionate (FP) on the vascular component of airway remodeling in 30 mild to moderate asthmatics. We also studied the effect on the inflammatory cells and the basement membrane thickness and we compared findings from bronchial biopsy taken in asthmatics to those in 8 controls. Bronchial responsiveness to methacholine and asthma symptom score were measured before and after treatments. Eight patients in the low dose FP group and eight patients in high dose FP group completed the study. At baseline, asthmatics showed an increase in the number of vessels and in vascular area as compared to controls. In asthmatics, number of vessels correlated with vascular area (p<0.01) and with number of mast cells (p<0.01). Bronchial responsiveness to methacholine, asthma symptom score and inflammatory cells decreased significantly after the low and high dose FP (p<0.05). However, the number of vessels, vascular area and the basement membrane thickness decreased only after high dose FP (p<0.05). In conclusion, this study shows that in mild to moderate asthmatic patients, high dose of inhaled FP given over 6 weeks, can significantly affect airway remodeling, by reducing both submucosal vascularity and basement membrane thickness.
Key words: Asthma; Airway Inflammation; Inhaled Steroids; Bronchial Biopsy
This article has been cited by other articles:

|
 |

|
 |
 
A. Zanini, A. Chetta, and D. Olivieri
Review: Therapeutic perspectives in bronchial vascular remodeling in COPD
Therapeutic Advances in Respiratory Disease,
June 1, 2008;
2(3):
179 - 187.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Siddiqui, F. Hollins, S. Saha, and C. E. Brightling
Inflammatory cell microlocalisation and airway dysfunction: cause and effect?
Eur. Respir. J.,
December 1, 2007;
30(6):
1043 - 1056.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. H. Walters, D. W. Reid, D. P. Johns, and C. Ward
Nonpharmacological and pharmacological interventions to prevent or reduce airway remodelling
Eur. Respir. J.,
September 1, 2007;
30(3):
574 - 588.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Cohen, X. E, J. Tarsi, T. Ramkumar, T. K. Horiuchi, R. Cochran, S. DeMartino, K. B. Schechtman, I. Hussain, M. J. Holtzman, et al.
Epithelial Cell Proliferation Contributes to Airway Remodeling in Severe Asthma
Am. J. Respir. Crit. Care Med.,
July 15, 2007;
176(2):
138 - 145.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Lloyd and D. S. Robinson
Allergen-induced airway remodelling
Eur. Respir. J.,
May 1, 2007;
29(5):
1020 - 1032.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kanazawa, S. Nomura, and K. Asai
Roles of Angiopoietin-1 and Angiopoietin-2 on Airway Microvascular Permeability in Asthmatic Patients
Chest,
April 1, 2007;
131(4):
1035 - 1041.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B N Feltis, D Wignarajah, D W Reid, C Ward, R Harding, and E H Walters
Effects of inhaled fluticasone on angiogenesis and vascular endothelial growth factor in asthma
Thorax,
April 1, 2007;
62(4):
314 - 319.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. de Paulis, N. Prevete, I. Fiorentino, F. W. Rossi, S. Staibano, N. Montuori, P. Ragno, A. Longobardi, B. Liccardo, A. Genovese, et al.
Expression and Functions of the Vascular Endothelial Growth Factors and Their Receptors in Human Basophils
J. Immunol.,
November 15, 2006;
177(10):
7322 - 7331.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Barbato, G. Turato, S. Baraldo, E. Bazzan, F. Calabrese, C. Panizzolo, M. E. Zanin, R. Zuin, P. Maestrelli, L. M. Fabbri, et al.
Epithelial Damage and Angiogenesis in the Airways of Children with Asthma
Am. J. Respir. Crit. Care Med.,
November 1, 2006;
174(9):
975 - 981.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. O'Byrne, S. Pedersen, W. W. Busse, W. C. Tan, Y.-Z. Chen, S. V. Ohlsson, A. Ullman, C. J. Lamm, and R. A. Pauwels
Effects of Early Intervention With Inhaled Budesonide on Lung Function in Newly Diagnosed Asthma
Chest,
June 1, 2006;
129(6):
1478 - 1485.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Guddo, A. M. Vignola, M. Saetta, S. Baraldo, L. Siena, E. Balestro, R. Zuin, A. Papi, P. Maestrelli, L. M. Fabbri, et al.
Upregulation of basic fibroblast growth factor in smokers with chronic bronchitis
Eur. Respir. J.,
May 1, 2006;
27(5):
957 - 963.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. S. Mendes, M. A. Campos, and A. Wanner
Airway Blood Flow Reactivity in Healthy Smokers and in Ex-Smokers With or Without COPD.
Chest,
April 1, 2006;
129(4):
893 - 898.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Bergeron and L.-P. Boulet
Structural changes in airway diseases: characteristics, mechanisms, consequences, and pharmacologic modulation.
Chest,
April 1, 2006;
129(4):
1068 - 1087.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. O. Abdel-Rahman, S. A. F. El-Sahrigy, and S. I. Bakr
A comparative study of two angiogenic factors: vascular endothelial growth factor and angiogenin in induced sputum from asthmatic children in acute attack.
Chest,
February 1, 2006;
129(2):
266 - 271.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Horvath and A. Wanner
Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma
Eur. Respir. J.,
January 1, 2006;
27(1):
172 - 187.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hashimoto, H. Tanaka, and S. Abe
Quantitative Analysis of Bronchial Wall Vascularity in the Medium and Small Airways of Patients With Asthma and COPD
Chest,
March 1, 2005;
127(3):
965 - 972.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Homer and J. A. Elias
Airway Remodeling in Asthma: Therapeutic Implications of Mechanisms
Physiology,
February 1, 2005;
20(1):
28 - 35.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Foresi, B. Mastropasqua, A. Chetta, R. D'Ippolito, R. Testi, D. Olivieri, and A. Pelucchi
Step-Down Compared to Fixed-Dose Treatment With Inhaled Fluticasone Propionate in Asthma
Chest,
January 1, 2005;
127(1):
117 - 124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Tomic, C. C. Lassiter, J. D. Ritzenthaler, H. N. Rivera, and J. Roman
Anti-Tissue Remodeling Effects of Corticosteroids: Fluticasone Propionate Inhibits Fibronectin Expression in Fibroblasts
Chest,
January 1, 2005;
127(1):
257 - 265.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Chanez, A. Bourdin, I. Vachier, P. Godard, J. Bousquet, and A. M. Vignola
Effects of Inhaled Corticosteroids on Pathology in Asthma and Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
November 1, 2004;
1(3):
184 - 190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Wanner, G. Horvath, J. L. Brieva, S. D. Kumar, and E. S. Mendes
Nongenomic Actions of Glucocorticosteroids on the Airway Vasculature in Asthma
Proceedings of the ATS,
November 1, 2004;
1(3):
235 - 238.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. S. Mendes, M. A. Campos, A. Hurtado, and A. Wanner
Effect of Montelukast and Fluticasone Propionate on Airway Mucosal Blood Flow in Asthma
Am. J. Respir. Crit. Care Med.,
May 15, 2004;
169(10):
1131 - 1134.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kanazawa, S. Nomura, and J. Yoshikawa
Role of Microvascular Permeability on Physiologic Differences in Asthma and Eosinophilic Bronchitis
Am. J. Respir. Crit. Care Med.,
May 15, 2004;
169(10):
1125 - 1130.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Tobin
Asthma, Airway Biology, and Nasal Disorders in AJRCCM 2003
Am. J. Respir. Crit. Care Med.,
January 15, 2004;
169(2):
265 - 276.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Tanaka, G. Yamada, T. Saikai, M. Hashimoto, S. Tanaka, K. Suzuki, M. Fujii, H. Takahashi, and S. Abe
Increased Airway Vascularity in Newly Diagnosed Asthma Using a High-magnification Bronchovideoscope
Am. J. Respir. Crit. Care Med.,
December 15, 2003;
168(12):
1495 - 1499.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Wenzel, H. W. Chu, P. Silkoff, S. O'Sullivan, L. Poulter, M. Akveld, and C. M. Burke
Ensuring Quality in Pharmaceutical Studies
Am. J. Respir. Crit. Care Med.,
October 15, 2003;
168(8):
1010 - 1012.
[Full Text]
|
 |
|
Copyright © 2002 American Thoracic Society
|
|
|